These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 11857021)
1. Evaluation of MAGE-1 and MAGE-3 as tumour-specific markers to detect blood dissemination of hepatocellular carcinoma cells. Mou DC; Cai SL; Peng JR; Wang Y; Chen HS; Pang XW; Leng XS; Chen WF Br J Cancer; 2002 Jan; 86(1):110-6. PubMed ID: 11857021 [TBL] [Abstract][Full Text] [Related]
2. [Detection of alpha-fetoproteins mRNA and melanoma antigen-1 mRNA in peripheral blood of patients with hepatocellular carcinoma and its clinical significance]. Yang SZ; Dong JH; Zhu J; Li K; Zhang Y Zhonghua Wai Ke Za Zhi; 2004 Sep; 42(17):1060-3. PubMed ID: 15498320 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of cancer-testis antigen mRNA in peripheral blood from hepatocellular carcinoma patients. Zhao L; Mou DC; Peng JR; Huang L; Wu ZA; Leng XS World J Gastroenterol; 2010 Aug; 16(32):4072-8. PubMed ID: 20731022 [TBL] [Abstract][Full Text] [Related]
4. Melanoma antigen-1 mRNA combined with alpha-fetoprotein mRNA levels in peripheral blood of patients with hepatocellular carcinoma: a predictor of postoperative recurrence or metastasis? Zhang Y; Song T; Meng L; Wu X; Ba Y; Li Q ANZ J Surg; 2009; 79(1-2):62-9. PubMed ID: 19183381 [TBL] [Abstract][Full Text] [Related]
5. Detection of AFPmRNA and melanoma antigen gene-1mRNA as markers of disseminated hepatocellular carcinoma cells in blood. Yang SZ; Dong JH; Li K; Zhang Y; Zhu J Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):227-33. PubMed ID: 15908320 [TBL] [Abstract][Full Text] [Related]
6. [Perioperative detection of MAGE-1mRNA and AFP mRNA in peripheral blood of patients with hepatocellular carcinoma: relationships with recurrence]. Yang SZ; Dong JH; Zhu J; Li K; Zhang Y Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(9):595-8. PubMed ID: 15949354 [TBL] [Abstract][Full Text] [Related]
7. mRNA of MAGE genes as specific markers in detection of tumor cells in the peripheral blood of patients with hepatocellular carcinoma. Peng J; Cai S; Leng X; Mu D; Lu J; Chen H; Rui J Zhonghua Yu Fang Yi Xue Za Zhi; 2002 Dec; 36(7):487-90. PubMed ID: 12411150 [TBL] [Abstract][Full Text] [Related]
8. Detection of MAGE-1, MAGE-3 and AFP mRNA as multimarker by real-time quantitative PCR assay: a possible predictor of hematogenous micrometastasis of hepatocellular carcinoma. Zhang Y; Li Q; Liu N; Song T; Liu Z; Guo R; Meng L Hepatogastroenterology; 2008; 55(88):2200-6. PubMed ID: 19260505 [TBL] [Abstract][Full Text] [Related]
9. MAGE-4 gene m-RNA and TGF in blood as potential biochemical markers for HCC in HCV-infected patients. Hussein YM; Morad FE; Gameel MA; Emam WA; El Sawy WH; El Tarhouny SA; Bayomy ES; Raafat N Med Oncol; 2012 Dec; 29(5):3055-62. PubMed ID: 22653756 [TBL] [Abstract][Full Text] [Related]
10. Human telomerase reverse transcriptase messenger RNA (TERT mRNA) as a tumour marker for early detection of hepatocellular carcinoma. El-Mazny A; Sayed M; Sharaf S Arab J Gastroenterol; 2014 Jun; 15(2):68-71. PubMed ID: 25097049 [TBL] [Abstract][Full Text] [Related]
11. [Detection of tumor cells in peripheral blood of patients with gastric cancer using mRNA of MAGE genes as markers]. Wang WX; Li YB; Xie XL; Shu XL; Ouyang XH Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Nov; 12(6):611-4. PubMed ID: 19921576 [TBL] [Abstract][Full Text] [Related]
12. Detection of α-fetoprotein and glypican-3 mRNAs in the peripheral blood of hepatocellular carcinoma patients by using multiple FQ-RT-PCR. Yan D; He Q; Chen Y; Wang L; Zhang X J Clin Lab Anal; 2011; 25(2):113-7. PubMed ID: 21438004 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of MAGE-D4 expression in hepatocellular carcinoma in Japanese patients. Takami H; Kanda M; Oya H; Hibino S; Sugimoto H; Suenaga M; Yamada S; Nishikawa Y; Asai M; Fujii T; Nomoto S; Kodera Y J Surg Oncol; 2013 Dec; 108(8):557-62. PubMed ID: 24068544 [TBL] [Abstract][Full Text] [Related]
14. [Melanoma antigen-3 expression in human hepatocellular carcinoma]. Cai S; Zhao H; Leng X; Cheng J; Gong S; Peng J; Cong X; Wang Y; Rui J; Hui Y; Du R; Chen W Zhonghua Wai Ke Za Zhi; 2000 Sep; 38(9):693-6. PubMed ID: 11832142 [TBL] [Abstract][Full Text] [Related]
15. Expression of MAGE, GAGE and BAGE genes in human liver diseases: utility as molecular markers for hepatocellular carcinoma. Kobayashi Y; Higashi T; Nouso K; Nakatsukasa H; Ishizaki M; Kaneyoshi T; Toshikuni N; Kariyama K; Nakayama E; Tsuji T J Hepatol; 2000 Apr; 32(4):612-7. PubMed ID: 10782910 [TBL] [Abstract][Full Text] [Related]
16. Quantitation of alpha-fetoprotein messenger RNA for early detection of recurrent hepatocellular carcinoma: a prospective pilot study. Schmilovitz-Weiss H; Stemmer SM; Liberzon E; Avigad S; Sulkes J; Belinki A; Kazatsker A; Ben-Ari Z Cancer Detect Prev; 2006; 30(2):204-9. PubMed ID: 16638626 [TBL] [Abstract][Full Text] [Related]
17. Semiquantification of circulating hepatocellular carcinoma cells by reverse transcriptase polymerase chain reaction. Wong IH; Leung T; Ho S; Lau WY; Chan M; Johnson PJ Br J Cancer; 1997; 76(5):628-33. PubMed ID: 9303362 [TBL] [Abstract][Full Text] [Related]
18. MAGE-3 and MAGE-4 genes as possible markers for early detection of metastases in hepatitis C virus Egyptian patients complicated by hepatocellular carcinoma. Hussein YM; Ghareib AF; Mohamed RH; Radwan MI; Elsawy WH Med Oncol; 2012 Jun; 29(2):994-9. PubMed ID: 21452042 [TBL] [Abstract][Full Text] [Related]
19. Expression of MAGE genes and survival in patients with hepatocellular carcinoma. Suzuki K; Tsujitani S; Konishi I; Yamaguchi Y; Hirooka Y; Kaibara N Int J Oncol; 1999 Dec; 15(6):1227-32. PubMed ID: 10568832 [TBL] [Abstract][Full Text] [Related]